Vincerx Pharma, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vincerx Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • Vincerx Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$7.84M, a 12.9% increase year-over-year.
  • Vincerx Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$27M, a 41.8% increase year-over-year.
  • Vincerx Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$40.2M, a 36.2% increase from 2022.
  • Vincerx Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$63M, a 60.2% decline from 2021.
  • Vincerx Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$39.3M, a 136% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$40.2M +$22.8M +36.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 -$63M -$23.7M -60.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$39.3M -$22.7M -136% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$16.6M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.